staar.com (STAA): Operatsion rentabellik

STAAR Surgical Company (STAA) - korporativ logo

STAAR Surgical Company (STAA) barqarorligi Osiyo geosiyosiy xatarlariga nisbatan chidamliligi bilan tasdiqlanadi, buni GURU.Markets platformasida asosiy operatsion foyda marjasini kuzatish jarayonida 6.70 orqali joriy metrika darajasi sifatida qayd etamiz. Operatsion baza tanlovli xizmatlar bilan birga sog'liqni saqlash sektorining defensiv xususiyatlari va har qanday kompetentsiya bo'shliqlarini bartaraf etuvchi kuchli R&D pipeline muvozanatiga tayanadi. Bunday poydevor xarajatlar nazoratini kafolatlaydi va biznes uchun xavfsiz boshpana marjasini ta'minlaydi.

STAA - STAAR Surgical Operatsion foyda koeffitsiyenti 04.07.2022 - 20.11.2026 oraligʻida

STAA (STAAR Surgical): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Fundamental baholash:STAAR Surgical Co., STAA
staar.com asosiy tovari

STAAR Surgical Company (STAA) uchun GURU.Markets platformasidagi operatsion foyda marjasi implantatsiya qilinadigan linzalarning ishlab chiqarish samaradorligini aks ettiradi. Ushbu ko'rsatkich soliqlar va qarz majburiyatlarining ta'sirini hisobga olmagan holda, operatsion foydaning tushumga nisbati sifatida hisoblanadi. Mazkur metrika biznesning savdoni moliyaviy leverajdan oldin foydaga aylantirish qobiliyatini o'lchaydi. Yuqori marjalar miniaturizatsiya qilingan mahsulotlar uchun noyob avtomatlashtirish texnologiyasining kengaytiriluvchanligini tasdiqlaydi. Ushbu ko'rsatkichning barqaror o'sishi modelning fundamental barqarorligi va yuqori daromadliligidan dalolat beradi.

Asosiy raqobatchilar

ISRG (intuitive.com) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi DHR (Danaher Corp.)|Sotuvning operatsion marjasi BDX (Becton, Dickinson and Company)|Operatsion foyda koeffitsiyenti STE|Operatsion rentabellik West Pharma WST|Operatsion faoliyat rentabelligi Baxter (BAX)|MASI - Operatsion rentabellik|Operatsion faoliyat rentabelligi Stevanato Group Corp STVN|TFX: Operatsion marja|Sotuvning operatsion marjasi Merit Medical Systems|Operatsion rentabellik Envista Holdings Corp|Sotuvning operatsion marjasi ICU Medical Corp (ICUI)|Operatsion rentabellik DENTSPLY SIRONA Inc. (XRAY)|Sotuvning operatsion marjasi LeMaitre LMAT|Operatsion marja ATRC (atricure.com)|ChromaDex Corporation (NAGE) - Sotuvning operatsion rentabelligi|ZimVie Inc - Operatsion marja|Sotuvning operatsion rentabelligi AngioDynamics|CERS (Cerus Corp) - Sotuvning operatsion marjasi|Alpha Teknova, Inc. - Operatsion foyda normasi|MGRM (Monogram Orthopedics Inc.) - Operatsion marja|STSS: Operatsion foyda normasi|Sotuvning operatsion marjasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja KRMD (korumedical.com)|Operatsion faoliyat rentabelligi Nyxoah, S.A. (NYXH)|MBOT - Operatsion rentabellik|PDEX (Pro-Dex, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|ZTEK (Zentek Ltd) - Sotuvning operatsion marjasi|ELUT - Operatsion faoliyat rentabelligi|MLSS (Milestone Scientific Corporation) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi NXGL (NEXGEL, Inc.)|Operatsion marja RVP|Sotuvning operatsion marjasi Harvard Bioscience HBIO|Operatsion marja FEMY (Femasys Corporation)|MHUA - Sotuvning operatsion marjasi|POAI - Operatsion rentabellik|Callan JMB (CJMB) - Sotuvning operatsion marjasi|ATRI: Operatsion marja|NURO - Operatsion faoliyat rentabelligi